drugset / Trial / NCT03851432
Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Janagliflozin compared to placebo, both in combination with Metformin, in Chinese patients with type 2 diabetes mellitus (T2DM) inadequately controlled with Metformin alone.
Timeline
- Start
- 2019-06-30
- Primary completion
- 2020-04-30
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Janagliflozin | Unknown | 25 mg | Oral |
| Subject | Janagliflozin | Unknown | 50 mg | Oral |
| Background | Metformin | Small molecule | — | — |